Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-01-22 Equity Swap | 2021-01-26 5:13 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer | 13,000 | $0 | 0 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:13 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer | 416,749 | $0 | 0 (Direct) | View |
| 2020-02-19 Option Award | 2020-03-11 4:52 pm | N/A 2030-02-19 | Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer | 54,000 | $0 | 54,000 (Direct) | View |
| 2019-12-24 Exercise | 2020-03-11 4:47 pm | N/A 2027-10-24 | Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer | 13,000 | $0 | 162,000 (Direct) | View |
| 2019-12-24 Exercise | 2020-03-11 4:47 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer | 13,000 | $0.18 | 162,000 (Direct) | View |
Ownership | 2019-06-19 6:28 pm | N/A 2027-10-24 | Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer | 0 | $0 | 375,749 (Direct) | View |